TY - JOUR
T1 - Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs
T2 - A case series
AU - Peeters, Laura
AU - van der Net, Jeroen B.
AU - Schoenmakers-Buis, Kathy
AU - van der Meer, Irene M
AU - Massey, Emma
AU - van Dijk, Liset
AU - van Gelder, Teun
AU - Koch, Birgit
AU - Versmissen, Jorie
PY - 2022
Y1 - 2022
N2 - Nonadherence to antihypertensive drugs is an important reason for not reaching blood pressure goals. A possible method to improve nonadherence involves three essential steps: identification of nonadherent patients (step 1), determination of underlying causes (step 2) and a personalized solution (step 3). We present three unique cases to show the importance and difficulties of this three-step approach. Patients participated in a randomized controlled trial to improve nonadherence to antihypertensive drugs (RHYME-RCT, Dutch Trial Register NL6736). Drug level measurements were used to identify nonadherence to antihypertensive drugs and communication on drug levels was supported by a tailored feedback tool in these patients. These cases showed that a three-step approach of identifying nonadherence and determination of the underlying cause, can lead to a personalized solution to improve therapy even when nonadherence was excluded. Open communication with patients remains an essential part when improving nonadherence.
AB - Nonadherence to antihypertensive drugs is an important reason for not reaching blood pressure goals. A possible method to improve nonadherence involves three essential steps: identification of nonadherent patients (step 1), determination of underlying causes (step 2) and a personalized solution (step 3). We present three unique cases to show the importance and difficulties of this three-step approach. Patients participated in a randomized controlled trial to improve nonadherence to antihypertensive drugs (RHYME-RCT, Dutch Trial Register NL6736). Drug level measurements were used to identify nonadherence to antihypertensive drugs and communication on drug levels was supported by a tailored feedback tool in these patients. These cases showed that a three-step approach of identifying nonadherence and determination of the underlying cause, can lead to a personalized solution to improve therapy even when nonadherence was excluded. Open communication with patients remains an essential part when improving nonadherence.
U2 - 10.1097/HJH.0000000000003001
DO - 10.1097/HJH.0000000000003001
M3 - Article
SN - 0263-6352
VL - 40
SP - 189
EP - 193
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 1
ER -